Was the Use of Antipsychotic Drugs with Arrythmogenic Potential Changed in the Last Years? A Population-Based, Database Study in five European Countries

Aug-12

Cardiovascular Database Mental Health Neurology Pharmacoepidemiology

AUTHORS : Gianluca Trifirò, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 1, Consolare Valeria Street, 98125, Messina, Italy / Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands – Email: trifirog@unime.it – Profile: https://www.unime.it/it/persona/gianluca-trifir%C3%B2 OR Dr Miriam Sturkenboom, Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands – Email: m.c.j.sturkenboom@umcutrecht.nl – Profile: https://www.umcutrecht.nl/en/research/researchers/sturkenboom-miriam-mcjm

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 21(S3):331-332

DOI : 10.1002/pds.3324

Was the Use of Antipsychotic Drugs with Arrythmogenic Potential Changed in the Last Years? A Population-Based, Database Study in five European Countries

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement